TLR9 and idiopathic pulmonary fibrosis: Furthermore, the more-robust activation profiles of fibroblasts isolated from patients with IPF and exposed to TLR9 agonist correlated with increased AHR activation in matched myeloid cells (30), indicating that AHR plays a fundamentally profibrotic role.